Cubist Systematic Strategies, LLC Cure Vac N.V. Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 51,174 shares of CVAC stock, worth $228,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,174Holding current value
$228,747% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding CVAC
# of Institutions
94Shares Held
10.7MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$10.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.82MShares$8.12 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$7.01 Million10.6% of portfolio
-
Ubs Group Ag843KShares$3.77 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0308KShares$1.38 Million0.08% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $838M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...